Bulpa P, Dive A, Sibille Y. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Eur Respir J. 2007;30:782–800.
Article
CAS
Google Scholar
Denning DW. The ambitious “95-95 by 2025” roadmap for the diagnosis and management of fungal diseases. Thorax. 2015;70:613–4.
Article
Google Scholar
Ader F, Nseir S, Le Berre R, Leroy S, Tillie-Leblond I, Marquette CH, Durocher A. Invasive pulmonary aspergillosis in chronic obstructive pulmonary disease: an emerging fungal pathogen. Clin Microbiol Infect. 2005;11:427–9.
Article
CAS
Google Scholar
Patel DA, Gao X, Stephens JM, Forshag MS, Tarallo M. US hospital database analysis of invasive aspergillosis in the chronic obstructive pulmonary disease non-traditional host. J Med Econ. 2011;14:227–37.
Article
Google Scholar
Russo A, Falcone M, Vena A, Venditti C, Mancini C, Morelli A, Venditti M. Invasive pulmonary aspergillosis in non-neutropenic patients: analysis of a 14-month prospective clinical experience. J Chemother. 2011;23:290–4.
Article
CAS
Google Scholar
Xu H, Li L, Huang WJ, Wang LX, Li WF, Yuan WF. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: a case control study from China. Clin Microbiol Infect. 2012;18:403–8.
Article
CAS
Google Scholar
Guinea J, Torres-Narbona M, Gijon P, Munoz P, Pozo F, Pelaez T, de Miguel J, Bouza E. Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome. Clin Microbiol Infect. 2010;16:870–7.
Article
CAS
Google Scholar
Benedict K, Richardson M, Vallabhaneni S, Jackson BR, Chiller T. Emerging issues, challenges, and changing epidemiology of fungal disease outbreaks. Lancet Infect Dis. 2017;17:e403–11.
Article
Google Scholar
Bassetti M, Righi E, De Pascale G, De Gaudio R, Giarratano A, Mazzei T, Morace G, Petrosillo N, Stefani S, Antonelli M. How to manage aspergillosis in non-neutropenic intensive care unit patients. Crit Care. 2014;18:458.
Article
Google Scholar
Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187:347–65.
Article
CAS
Google Scholar
Bursac Z, Gauss CH, Williams DK, Hosmer DW. Purposeful selection of variables in logistic regression. Source Code Biol Med. 2008;3:17.
Article
Google Scholar
Nattino G, Finazzi S, Bertolini G. A new test and graphical tool to assess the goodness of fit of logistic regression models. Stat Med. 2016;35:709–20.
Article
Google Scholar
Van Calster B, Wynants L, Verbeek JFM, Verbakel JY, Christodoulou E, Vickers AJ, Roobol MJ, Steyerberg EW. Reporting and interpreting decision curve analysis: a guide for investigators. Eur Urol. 2018;74:796–804.
Article
Google Scholar
Guinea J, Jensen J, Pelaez T, Gijon P, Alonso R, Rivera M, Munoz P, Bouza E. Value of a single galactomannan determination (Platelia) for the diagnosis of invasive aspergillosis in non-hematological patients with clinical isolation of Aspergillus spp. Med Mycol. 2008;46:575–9.
Article
CAS
Google Scholar
Stuck AE, Minder CE, Frey FJ. Risk of infectious complications in patients taking glucocorticosteroids. Rev Infect Dis. 1989;11:954–63.
Article
CAS
Google Scholar
Donnelly JP, Chen SC, Kauffman CA, Steinbach WJ, Baddley JW, Verweij PE, Clancy CJ, Wingard JR, Lockhart SR, Groll AH, et al. Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clin Infect Dis. 2020;71:1367–76.
Article
Google Scholar
Palmer LB, Greenberg HE, Schiff MJ. Corticosteroid treatment as a risk factor for invasive aspergillosis in patients with lung disease. Thorax. 1991;46:15–20.
Article
CAS
Google Scholar
Leav BA, Fanburg B, Hadley S. Invasive pulmonary aspergillosis associated with high-dose inhaled fluticasone. N Engl J Med. 2000;343:586.
Article
CAS
Google Scholar
Schelenz S, Barnes RA, Barton RC, Cleverley JR, Lucas SB, Kibbler CC, Denning DW, British Society for Medical M. British Society for Medical Mycology best practice recommendations for the diagnosis of serious fungal diseases. Lancet Infect Dis. 2015;15:461–74.
Article
Google Scholar
Ullmann AJ, Aguado JM, Arikan-Akdagli S, Denning DW, Groll AH, Lagrou K, Lass-Florl C, Lewis RE, Munoz P, Verweij PE, et al. Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline. Clin Microbiol Infect. 2018;24(Suppl 1):e1–38.
Article
Google Scholar
Blot SI, Taccone FS, Van den Abeele AM, Bulpa P, Meersseman W, Brusselaers N, Dimopoulos G, Paiva JA, Misset B, Rello J, et al. A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients. Am J Respir Crit Care Med. 2012;186:56–64.
Article
Google Scholar
Hamam J, Navellou JC, Bellanger AP, Bretagne S, Winiszewski H, Scherer E, Piton G, Millon L, Collaborative Rg. New clinical algorithm including fungal biomarkers to better diagnose probable invasive pulmonary aspergillosis in ICU. Ann Intensive Care. 2021;11:41.
Article
Google Scholar
Huang L, He H, Jin J, Zhan Q. Is Bulpa criteria suitable for the diagnosis of probable invasive pulmonary Aspergillosis in critically ill patients with chronic obstructive pulmonary disease? A comparative study with EORTC/ MSG and ICU criteria. BMC Infect Dis. 2017;17:209.
Article
Google Scholar
Delsuc C, Cottereau A, Frealle E, Bienvenu AL, Dessein R, Jarraud S, Dumitrescu O, Le Marechal M, Wallet F, Friggeri A, et al. Putative invasive pulmonary aspergillosis in critically ill patients with chronic obstructive pulmonary disease: a matched cohort study. Crit Care. 2015;19:421.
Article
Google Scholar
Bulpa P, Bihin B, Dimopoulos G, Taccone FS, Van den Abeele AM, Misset B, Meersseman W, Spapen H, Cardoso T, Charles PE, et al. Which algorithm diagnoses invasive pulmonary aspergillosis best in ICU patients with COPD? Eur Respir J. 2017. https://doi.org/10.1183/13993003.00532-2017.
Article
PubMed
Google Scholar
Teering S, Verreth A, Peeters A, Van Regenmortel N, De Laet I, Schoonheydt K, Dits H, Van De Vyvere M, Libeer C, Meersseman W, Malbrain ML. Prognostic value of serum galactomannan in mixed ICU patients: a retrospective observational study. Anaesthesiol Intensive Ther. 2014;46:145–54.
Article
Google Scholar
Fortun J, Martin-Davila P, Gomez Garcia de la Pedrosa E, Silva JT, Garcia-Rodriguez J, Benito D, Venanzi E, Castano F, Fernandez-Ruiz M, Lazaro F, et al. Galactomannan in bronchoalveolar lavage fluid for diagnosis of invasive aspergillosis in non-hematological patients. J Infect. 2016;72:738–44.
Article
CAS
Google Scholar
He H, Ding L, Sun B, Li F, Zhan Q. Role of galactomannan determinations in bronchoalveolar lavage fluid samples from critically ill patients with chronic obstructive pulmonary disease for the diagnosis of invasive pulmonary aspergillosis: a prospective study. Crit Care. 2012;16:R138.
Article
Google Scholar